2000
DOI: 10.1128/cdli.7.4.658-661.2000
|View full text |Cite
|
Sign up to set email alerts
|

Use of Synthetic Cardiolipin and Lecithin in the Antigen Used by the Venereal Disease Research Laboratory Test for Serodiagnosis of Syphilis

Abstract: The Venereal Disease Research Laboratory (VDRL) test is a microflocculation test for syphilis that uses an antigen containing cardiolipin, lecithin, and cholesterol. For more than 50 years, the preparation of natural cardiolipin and lecithin for this test has been based on the Pangborn method which involves isolating and purifying these components from beef hearts. This process is tedious and time-consuming and results in a variable purity range. In our studies, we found that a VDRL antigen using synthetic tet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2001
2001
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 7 publications
0
6
0
Order By: Relevance
“…We observed that 13% of LA‐positive, 10% of anti‐ ß2GP1‐positive and 18% of aCL‐positive samples tested falsely positive in the FVIII IgG ELISA. This finding is not surprising given that FVIII inhibitors and LA/APA antibodies reportedly target similar epitopes in the C2 domain of FVIII [5,27–30]. Antibodies that form in patients with FVIII inhibitors may have multiple epitope targets, whereas LA may bind only to the phospholipid‐binding site (C2) on FVIII.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We observed that 13% of LA‐positive, 10% of anti‐ ß2GP1‐positive and 18% of aCL‐positive samples tested falsely positive in the FVIII IgG ELISA. This finding is not surprising given that FVIII inhibitors and LA/APA antibodies reportedly target similar epitopes in the C2 domain of FVIII [5,27–30]. Antibodies that form in patients with FVIII inhibitors may have multiple epitope targets, whereas LA may bind only to the phospholipid‐binding site (C2) on FVIII.…”
Section: Discussionmentioning
confidence: 99%
“…This interference from LA and APAs seems to be directed specifically against a phospholipid epitope in the FVIII molecule as other IgG antibodies did not interfere with the FVIII immunoassay. It is not surprising that two of six VDRL‐positive sera tested positive in FVIII IgG ELISA assay, since cardiolipin is the main source of the antigen mixture in the flocculation assays [30]. Of note, there was no interference from LA or APA in FIX IgG immunoassay.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, a synthetic VDRL antigen has been developed using tetramyristoyl cardiolipin and synthetic 1-palmitoyl-2oleoyl-sn-glycerol-3-phosphocholine and was shown to be as specific in detecting syphilis as a VDRL antigen made with natural components. 8 Moreover, this synthetic antigen had a higher level of reactivity with 85% (169/200) of the positive specimens tested than the natural VDRL antigen. The purity of the synthetic VDRL antigen was greater than 99%, which should eliminate this variabile as well as problems with stability that have been encountered with reagents prepared with natural VDRL antigen.…”
Section: Syphilismentioning
confidence: 93%
“…The non-treponemal antigen was prepared by using synthetic VDRL antigen made from an ethanolic solution of 0.03% tetramyristoyl cardiolipin, 0.14% 1-palmitoyl-2-oleolyl-sn-glycero-3-phosphocholine, lecithin and 0.9% cholesterol (Avanti Polar Lipids, Alabaster, Alabama, USA) 12. A 1:10 emulsion of this antigen in phosphate buffered saline was prepared according to the standard VDRL procedure13 and centrifuged at 4360 g for 45 min and resuspended in 10 mM phosphate buffer pH 6.9 containing 0.25 M EDTA, 0.72 M choline chloride and 0.01% sodium azide.…”
Section: Methodsmentioning
confidence: 99%